These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 36653533)
1. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland. Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533 [TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c. Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970 [TBL] [Abstract][Full Text] [Related]
3. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades? Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701 [TBL] [Abstract][Full Text] [Related]
4. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus. Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316 [TBL] [Abstract][Full Text] [Related]
5. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol. Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458 [TBL] [Abstract][Full Text] [Related]
6. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E; Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468 [TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847 [TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes. Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886 [TBL] [Abstract][Full Text] [Related]
9. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol. Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR; BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714 [TBL] [Abstract][Full Text] [Related]
10. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection. Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863 [TBL] [Abstract][Full Text] [Related]
11. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z Front Public Health; 2022; 10():990281. PubMed ID: 36091534 [TBL] [Abstract][Full Text] [Related]
12. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study. Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663 [TBL] [Abstract][Full Text] [Related]
13. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [TBL] [Abstract][Full Text] [Related]
14. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes. Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211 [TBL] [Abstract][Full Text] [Related]
15. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Moreno-Fernandez J; Chico A; Martínez-Brocca MA; Beato-Víbora PI; Vidal M; Piedra M; Quirós C; Muñoz-Rodríguez JR; Diabetes Technol Ther; 2022 Dec; 24(12):898-906. PubMed ID: 35947087 [No Abstract] [Full Text] [Related]
16. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Farrar D; Tuffnell DJ; West J; West HM Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351 [TBL] [Abstract][Full Text] [Related]
17. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417 [TBL] [Abstract][Full Text] [Related]
18. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study. Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006 [TBL] [Abstract][Full Text] [Related]
19. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes. Stewart ZA; Thomson L; Murphy HR; Beardsall K Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640 [TBL] [Abstract][Full Text] [Related]
20. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]